These results suggest that PSAP deficiency may promote the formation of NFTs in conjunction with the reduction of PGRN, and that the interaction between PSAP and PGRN may be inhibited during the pathologic process of NFTs, which in turn exacerbates the pathologic process of AD. This evidence concerns the gene PSAP and Alzheimer disease.